Protalix BioTherapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Protalix BioTherapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q4 2023.
  • Protalix BioTherapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2023 was 73M shares, a 35.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 73M +19.2M +35.6% Dec 31, 2023 10-K 2024-03-14
Q4 2022 53.8M +8.23M +18.1% Dec 31, 2022 10-K 2024-03-14
Q4 2021 45.6M +10.8M +31% Dec 31, 2021 10-K 2023-02-27
Q4 2020 34.8M +19.9M +134% Dec 31, 2020 10-K 2022-03-31
Q4 2019 14.8M 0 0% Dec 31, 2019 10-K 2021-03-30
Q4 2018 14.8M -129M -89.7% Dec 31, 2018 10-K 2020-03-12
Q4 2017 144M +19.6M +15.8% Dec 31, 2017 10-K 2019-03-18
Q4 2016 124M +24.3M +24.4% Dec 31, 2016 10-K 2018-03-06
Q4 2015 99.8M +6.2M +6.62% Dec 31, 2015 10-K 2017-03-16
Q4 2014 93.6M +52.7K +0.06% Dec 31, 2014 10-K 2016-03-08
Q4 2013 93.6M +61.3K +0.07% Dec 31, 2013 10-K 2015-03-12
Q4 2012 93.5M +7.86M +9.18% Dec 31, 2012 10-K 2014-03-13
Q4 2011 85.6M +4.38M +5.39% Dec 31, 2011 10-K 2013-02-28
Q4 2010 81.2M Dec 31, 2010 10-K 2012-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.